Navigation Links
Rapid Fire Marketing: Medical Cannabis Management Cleared for Medical Cannabis Cultivation
Date:4/11/2011

CARSON CITY, Nev., April 11, 2011 /PRNewswire/ -- Rapid Fire Marketing (Pink Sheets: RFMK) announced today that their wholly owned subsidiary, Medical Cannabis Management (MCM), has been cleared through all legal channels to begin cultivation and growing of medical cannabis. Management of MCM believes that this new division of the Company's business will significantly increase revenue and earnings through 2011 and beyond. This represents a substantial and considerable income stream which the Company expects to realize within just a few months.

With the passing of Proposition 215, making medical cannabis legal in the state of California, Rapid Fire Marketing through MCM has entered the business of providing full service marketing, consulting and management services to this newly emerged industry, which will now include cultivation of medical cannabis. Rapid Fire Marketing is positioned to handle the demand of services needed by this new generation of small business entrepreneurs, with plans to capitalize on this exploding industry and generate revenue through service management contracts. Additional information can be found at http://www.medicalcannabismanagement.com.

"Needless to say, the legal ability to cultivate and grow medical cannabis would add a substantial amount of revenue to our business. We are in the process of finalizing details on the logistics of this new division of our business and we expect to be up and running by early summer," a Company spokesperson stated.

Contact@MedicalCannabisManagement.com

Safe Harbor:

From time to time, the Company may issue news releases that contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. For those statements, the Company claims the protection of the safe harbor for forward-looking statement provisions contained in the Private Securities Litigation Reform Act of 1995 and any amendments thereto. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be "forward-looking statements." "Forward-looking statements" are based upon expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those anticipated.


'/>"/>
SOURCE Rapid Fire Marketing
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cepheid Extends Rapid Molecular Diagnostics Leadership with FDA Clearance of Xpert Clostridium difficile/Epi
2. Digital Assent Expands Leadership Team to Address Rapidly Growing Demand for the PatientPad
3. Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012
4. Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study
5. Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
6. Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems
7. Reprints Desk Bolsters Ultra-Rapid Document Delivery Service Through New Electronic Sourcing Agreement with the American Medical Association, Publisher of JAMA & Archives Journals
8. New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
9. Marken Rapidly Responds to Global Supply Chain Security Measures
10. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
11. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... 2017 , ... RawTrition now brings you BioEnergy which is a powder capsule ... , RawTrition is taking nutrients to the next level! The superfoods in ... raw form (unlike the synthetically made options that are on the market). , Founder ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... cream that’s the first in a new class of photodynamic cosmetics (PDC). , ... of skin, visibly reduce outward signs of aging, and minimize the appearance of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... CEOs, CFOs and HR decision-makers are preparing for how his administration could impact ... will provide insight into what changes are most likely to make it through ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... targets, they rely on contracted partners to help with process innovation in drug ... combined drug formulation experience along with state-of-the-art analytical equipment in support of their ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... of predictive analytics to its patient care management module. Using this new feature, ... a patient has been initiated on continuous positive airway pressure (CPAP), oral, or ...
Breaking Medicine News(10 mins):